Astellas Reaches U.S. Agreement on Medicine Affordability
TOKYO, Japan, Aug. 31, 2026 Astellas Pharma Inc. has entered into a voluntary agreement with the U.S. government designed...
Headache Disorders
Advertisement
AAN, AHS Update Migraine Prevention Medication Guidelines
MINNEAPOLIS, Minnesota, Aug. 31, 2026 The American Academy of Neurology (AAN) and the American Headache Society (AHS) have issued...
Ipsen Reports Positive Phase III Dysport Migraine Results
PARIS, France, July 9, 2026 Ipsen has announced positive topline Phase III results from its BEOND clinical development program,...
Lundbeck Reports Positive Phase IIb Migraine Trial Data
VALBY, Denmark, June 4, 2026 H. Lundbeck A/S has announced encouraging results from its Phase IIb PROCEED clinical trial...
Advertisement
